A detailed history of Marietta Investment Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Marietta Investment Partners LLC holds 166,437 shares of NVO stock, worth $19.8 Million. This represents 5.26% of its overall portfolio holdings.

Number of Shares
166,437
Previous 169,237 1.65%
Holding current value
$19.8 Million
Previous $21.7 Million 9.33%
% of portfolio
5.26%
Previous 4.82%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $343,588 - $411,348
-2,800 Reduced 1.65%
166,437 $23.8 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $21,749 - $28,950
213 Added 0.13%
169,237 $21.7 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $1.32 Million - $1.58 Million
14,982 Added 9.73%
169,024 $17.5 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $7.09 Million - $15.6 Million
77,930 Added 102.39%
154,042 $14 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $2.27 Million - $2.51 Million
14,561 Added 23.66%
76,112 $12.3 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $203,141 - $244,279
-1,535 Reduced 2.43%
61,551 $9.8 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $922 - $1,217
-9 Reduced 0.01%
63,086 $8.54 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $71,269 - $87,463
-748 Reduced 1.17%
63,095 $7.09 Million
Q2 2022

Aug 10, 2022

BUY
$103.24 - $121.81 $70,822 - $83,561
686 Added 1.09%
63,843 $7.11 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $100,548 - $121,543
-1,080 Reduced 1.68%
63,157 $7.01 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $93,003 - $113,567
970 Added 1.53%
64,237 $7.2 Million
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $22,793 - $28,787
270 Added 0.43%
63,267 $6.07 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $209,746 - $262,756
-3,100 Reduced 4.69%
62,997 $5.28 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $23,739 - $26,840
-354 Reduced 0.53%
66,097 $4.46 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $26,067 - $30,110
408 Added 0.62%
66,451 $4.64 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $552,574 - $609,228
8,676 Added 15.12%
66,043 $4.59 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $494,194 - $573,549
8,442 Added 17.25%
57,367 $3.76 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $350,918 - $459,614
7,095 Added 16.96%
48,925 $2.95 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $34,902 - $40,782
700 Added 1.7%
41,830 $2.42 Million
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $238,629 - $267,597
-5,100 Reduced 11.03%
41,130 $2.1 Million
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $461,094 - $524,475
-11,100 Reduced 19.36%
46,230 $2.13 Million
Q2 2017

Aug 14, 2017

BUY
N/A
57,330
57,330 $2.46 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marietta Investment Partners LLC Portfolio

Follow Marietta Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Investment Partners LLC with notifications on news.